Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service for decentralized access of protein biomarker and hereditary genetic testing; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, its pipeline products include OVAWatch, EndoCheck, and OVAInherit. The company serves physicians, physician office laboratories, and national and regional laboratories. It has a collaborative research agreement with Baylor Genetics; an agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas.
Over the last 12 months, insiders at Aspira Women's Health Inc. have bought $142,935 and sold $0 worth of Aspira Women's Health Inc. stock.
On average, over the past 5 years, insiders at Aspira Women's Health Inc. have bought $2.25M and sold $71,151 worth of stock each year.
Highest buying activity among insiders over the last 12 months: SCHULER JACK W (10 percent owner) — $548,750. Sandford Nicole (President & CEO) — $33,185.
The last purchase of 6,536 shares for transaction amount of $10,000 was made by SCHULER JACK W (10 percent owner) on 2024‑07‑09.
2024-07-09 | 10 percent owner | 6,536 0.0674% | $1.53 | $10,000 | -25.91% | |||
2024-05-31 | Chief Executive Officer | 9,493 0.1549% | $2.42 | $22,973 | -63.20% | |||
2024-01-26 | 10 percent owner | 28,500 0.6724% | $3.50 | $99,750 | -75.71% | |||
2024-01-26 | President & CEO | 2,400 0.0688% | $4.25 | $10,212 | -75.71% | |||
2023-12-06 | Sale | Secretary & General Counsel | 980 0.0223% | $3.37 | $3,303 | -38.36% | ||
2023-12-06 | President & CEO | 5,000 0.1133% | $3.36 | $16,800 | -38.36% | |||
2023-09-08 | Chief Financial Officer | 2,246 0.0651% | $4.30 | $9,658 | -18.52% | |||
2023-07-24 | 10 percent owner | 181,800 3.3703% | $2.75 | $499,950 | +41.43% | |||
2023-07-24 | President & CEO | 12,563 0.3371% | $3.98 | $50,001 | +41.43% | |||
2023-07-24 | director | 6,281 0.1685% | $3.98 | $24,998 | +41.43% | |||
2023-07-24 | director | 3,769 0.1011% | $3.98 | $15,001 | +41.43% | |||
2023-07-24 | director | 3,769 0.1011% | $3.98 | $15,001 | +41.43% | |||
2023-07-24 | director | 6,281 0.1685% | $3.98 | $24,998 | +41.43% | |||
2023-07-24 | director | 8,794 0.2359% | $3.98 | $35,000 | +41.43% | |||
2023-07-24 | director | 754 0.0202% | $3.98 | $3,001 | +41.43% | |||
2023-07-24 | CSO & COO | 628 0.0168% | $3.98 | $2,499 | +41.43% | |||
2023-07-24 | General counsel and secretary | 754 0.0202% | $3.98 | $3,001 | +41.43% | |||
2023-07-24 | Chief Financial Officer | 754 0.0202% | $3.98 | $3,001 | +41.43% | |||
2022-08-25 | 266,666 0.6741% | $0.38 | $100,000 | -26.00% | ||||
2022-08-25 | 13,332 – | $0 | $0 | -26.00% |
Sandford Nicole | Chief Executive Officer | 70596 0.4027% | $0.50 | 5 | 0 | +1.54% |
SCHULER JACK W | 10 percent owner | 6536 0.0373% | $0.50 | 19 | 0 | <0.0001% |
FEINBERG LARRY N | 10 percent owner | 9825289 56.0491% | $0.50 | 3 | 0 | <0.0001% |
Schuler Henri George | 10 percent owner | 6047057 34.4959% | $0.50 | 16 | 2 | +5.15% |
RATHMANN JAMES L | director | 4391877 25.0538% | $0.50 | 2 | 0 | |
RICH WILLIAM E | President/Chief Exec. Officer | 919119 5.2432% | $0.50 | 0 | 3 | |
PHRONESIS PARTNERS L P | 10 percent owner | 493611 2.8158% | $0.50 | 0 | 9 | |
Burns James S | director | 397055 2.265% | $0.50 | 2 | 0 | +23.74% |
LAFRANCE JAMES T | director | 298018 1.7001% | $0.50 | 5 | 4 | +31.39% |
GOGGIN ROBERT ST LEGER | director | 243685 1.3901% | $0.50 | 1 | 0 | +30.87% |
Palmieri Valerie Barber | President and CEO | 215563 1.2297% | $0.50 | 12 | 0 | +11.05% |
Beechey Robert Harry | Chief Financial Officer | 210000 1.198% | $0.50 | 5 | 0 | +54.08% |
Grossack Marshall J | EVP, Chief Actuary | 204860 1.1686% | $0.50 | 1 | 10 | |
Dupont Wesley D | EVP & General Counsel | 203488 1.1608% | $0.50 | 3 | 9 | +0.81% |
SCHREIBER DAVID | director | 185018 1.0554% | $0.50 | 0 | 3 | |
PAGE GAIL S | Chief Executive Officer | 139907 0.7981% | $0.50 | 2 | 1 | |
Carmilani Scott A | President, CEO and Chairman | 139000 0.7929% | $0.50 | 2 | 28 | +0.81% |
Severinghaus Carl | director | 137094 0.7821% | $0.50 | 1 | 3 | +30.87% |
Sharma Ruby | 127550 0.7276% | $0.50 | 1 | 0 | ||
Auerbach Robert D | director | 121492 0.6931% | $0.50 | 1 | 0 | <0.0001% |
DILLARD JOAN H | EVP & CFO | 113230 0.6459% | $0.50 | 3 | 13 | |
RODDY PETER S | director | 112862 0.6438% | $0.50 | 1 | 0 | +30.87% |
Gauthier John J | EVP & CIO | 66152 0.3774% | $0.50 | 2 | 0 | <0.0001% |
Fung Eric T | S.V.P & C.S.O | 52471 0.2993% | $0.50 | 3 | 0 | <0.0001% |
Jodoin Richard E | V. Chmn, AWAC(US) & AWNAC | 49524 0.2825% | $0.50 | 1 | 3 | |
Bell David | COO | 44717 0.2551% | $0.50 | 0 | 8 | |
Weinhoff Samuel J | director | 41825 0.2386% | $0.50 | 7 | 4 | +6214.96% |
HUEBNER BRUCE A | director | 40427 0.2306% | $0.50 | 2 | 0 | +5.91% |
Schwartz Eric S | director | 35000 0.1997% | $0.50 | 1 | 0 | +3% |
Cavanaugh Stefanie L. | director | 34904 0.1991% | $0.50 | 1 | 0 | +41.43% |
Jordan Veronica GH | director | 34575 0.1972% | $0.50 | 2 | 0 | +32.58% |
D'Orazio Frank | Pres. Bda & Int'l Ins., AWAC | 34525 0.197% | $0.50 | 0 | 9 | |
Vos Ellen O'Connor | director | 32878 0.1876% | $0.50 | 1 | 0 | +41.43% |
PATTERSON MARK R | director | 32698 0.1865% | $0.50 | 2 | 0 | |
Parnell Winfred | director | 31513 0.1798% | $0.50 | 1 | 0 | +41.43% |
Redmond John T | Pres, AWAC (Eur) & AWAC (Rein) | 31488 0.1796% | $0.50 | 1 | 7 | |
Creech William B. | VP, Sales and Marketing | 30137 0.1719% | $0.50 | 10 | 0 | <0.0001% |
Schoen Eric | Sr VP Finance & CAO | 29872 0.1704% | $0.50 | 3 | 0 | +24.54% |
Herchuk Jannie Prestridge | director | 23833 0.136% | $0.50 | 1 | 0 | +41.43% |
Knight W. Gordon | President, AWACUS & AWNAC | 19433 0.1109% | $0.50 | 0 | 13 | |
CALLAGHAN MICHAEL J | director | 17000 0.097% | $0.50 | 0 | 5 | |
Kohli Ashish | VP of Corporate Strategy | 13500 0.077% | $0.50 | 1 | 0 | <0.0001% |
Sennott John Langton JR | EVP, Chief Corp. Strat Officer | 13452 0.0767% | $0.50 | 1 | 0 | <0.0001% |
Fralick Celeste Rachelle | director | 12032 0.0686% | $0.50 | 2 | 0 | +41.43% |
McElroy John Justin | COO | 10456 0.0596% | $0.50 | 0 | 6 | |
BRADLEY THOMAS A | EVP & CFO | 8050 0.0459% | $0.50 | 2 | 0 | +2.41% |
de Saint-Aignan Patrick | director | 7820 0.0446% | $0.50 | 4 | 0 | <0.0001% |
FERRARA FRED | Chief Operating Officer | 6695 0.0382% | $0.50 | 1 | 0 | +23.74% |
Friedman Bart | director | 4204 0.024% | $0.50 | 1 | 0 | |
Phan Ryan Thinh | CSO & COO | 3939 0.0225% | $0.50 | 1 | 0 | +41.43% |
Hombeck Torsten | Chief Financial Officer | 3000 0.0171% | $0.50 | 2 | 0 | +11.45% |
ALEXANDER STILES BARBARA | director | 2000 0.0114% | $0.50 | 1 | 0 | +37400% |
DeFeo Philip D | director | 2000 0.0114% | $0.50 | 1 | 0 | |
VERHOEF MARTIN L | Sr VP, Sales, Marketing & Ops | 0 0% | $0.50 | 0 | 1 | |
Merchant Minh Hoang | Secretary & General Counsel | 0 0% | $0.50 | 1 | 1 | +41.43% |